Showcasing at the ASLS Bangkok International Academic Conference
[by Kang, In Hyo] L&C BIO, a regenerative medicine company, announced on September 4 its participation in the ‘ASLS BANGKOK 2025 International Conference of Aesthetic Medicine,’ held at the Avani + Riverside Bangkok Hotel, Thailand. At the event, the company presented its ECM-based skin booster, ‘Re2O,’ which attracted considerable attention in the ASEAN market.
Organized by the Aesthetic Surgery and Laser Society (ASLS), the ‘ASLS Bangkok International Conference of Aesthetic Medicine’ serves as a global academic platform for sharing the latest clinical knowledge and technological advances in medicine, dermatology, aesthetics, and plastic surgery. The annual event attracts a large number of Korean and international medical professionals and industry specialists, positioning itself as a venue for the exchange of practical clinical experience and emerging market trends.
This year's event drew approximately 1,000 participants, including medical professionals and industry representatives, with around 400 clinicians visiting the L&C BIO exhibition booth. At the scientific sessions, Choi Ho-seong, CEO of Piena Clinic, presented ‘hADM Injection" as a next-generation skin regeneration technology (breakthroughs), highlighting its clinical value and potential applications under the brand 무료 바카라 게임. The presentation attracted significant attention from attendees.
At the conference, ongoing questions and discussions focused on the safety profile and clinical differentiation of the product, reinforcing its potential for market expansion in the ASEAN region. Medical professionals from major ASEAN countries, including Indonesia, Malaysia, and Thailand, underscored 무료 바카라 게임's safety and distinct clinical value.
A key point of differentiation was the product's incorporation of human-derived extracellular matrix (ECM) rather than animal-based or synthetic ingredients, a feature associated with reduced risk of adverse effects and enhanced skin regenerative efficacy relative to existing products. Medical professionals at the site commented, "무료 바카라 게임 may represent an alternative capable of mitigating the side-effect profile of current products."
무료 바카라 게임 is a next-generation skin booster formulated with a high concentration of human-derived ECM components that facilitate skin tissue regeneration, repair, and elasticity improvement. In contrast to conventional hyaluronic acid (HA)-based products, 무료 바카라 게임 delivers unique ECM-derived biosignals that stimulate collagen and elastin remodeling, thereby fundamentally improving damaged skin conditions. According to the company, this innovative mechanism, which promotes intrinsic skin healing, is encapsulated in the concept of ‘adding skin to skin.’
"After the seminar in Singapore, 무료 바카라 게임 received an overwhelmingly positive response at the Thai academic society. Leveraging our clinical evidence and competitive quality, we plan to accelerate our entry into the ASEAN market and further drive overseas expansion through global academic societies and strategic partnerships," an L&C BIO official said.